RLF
MindMaze Therapeutics Holding SA
Stock
Stock
ISIN: CH1251125998
Ticker: RLF
CH1251125998
RLF
Price
Price
CHART BY
Frequently asked questions
What is MindMaze Therapeutics Holding SA's market capitalization?
The market capitalization of MindMaze Therapeutics Holding SA is $29.59M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for MindMaze Therapeutics Holding SA?
MindMaze Therapeutics Holding SA's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.555. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for MindMaze Therapeutics Holding SA's stock?
Currently, 0 analysts cover MindMaze Therapeutics Holding SA's stock, with a consensus target price of $3.126. Analyst ratings provide insights into the stock's expected performance.
What is MindMaze Therapeutics Holding SA's revenue over the trailing twelve months?
Over the trailing twelve months, MindMaze Therapeutics Holding SA reported a revenue of $4.64M.
What is the EBITDA for MindMaze Therapeutics Holding SA?
MindMaze Therapeutics Holding SA's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$7.37M. EBITDA measures the company's overall financial performance.
What is the free cash flow of MindMaze Therapeutics Holding SA?
MindMaze Therapeutics Holding SA has a free cash flow of -$3.92M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of MindMaze Therapeutics Holding SA's shares?
The free float of MindMaze Therapeutics Holding SA is 60.23M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $29.59M
- EPS (TTM)
- -$1.555
- Free Float
- 60.23M
- Revenue (TTM)
- $4.64M
- EBITDA (TTM)
- -$7.37M
- Free Cashflow (TTM)
- -$3.92M
Pricing
- 1D span
- $0.172$0.182
- 52W span
- $0.169$5.601
Analyst Ratings
Information
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- CH1251125998
- Primary Ticker
- RLF
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet